Home>Topics>Stocks>Progenics Pharmaceuticals

Progenics Pharmaceuticals PGNX

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. An Inefficient Stock Market Will Catch Up To Progenics

      Headlines

      Mon, 21 Jul 2014

      reflection of its value, and it can be vastly different than the current value of their future cash flows. Progenics (NASDAQ: PGNX ) appears to be a good example of an inefficient market. Last week, 30 days after a positive FDA Advisory Committee meeting

    2. Patient enrollment for Synergy OIC drug trial complete

      Headlines

      Thu, 17 Jul 2014

      bowel movements during Week 4 of the Treatment Period. Synergy intends to release top-line data from the trial in Q4. Related tickers: ( NKTR -5.2% ) ( AZN -2.1% ) ( CBST -0.8% ) ( SLXP -1.6% ) ( PGNX ) Post your comment!

    3. Premarket Gainers / Losers

      Headlines

      Mon, 14 Jul 2014

      Gainers: CREG +20% . PGNX +14% . EXEL +12% . KNDI +11% . URS +8% . APP +7% . DGLY +6% . ICPT +5% . Losers: GTAT -6% . Post your comment!

    4. Salix successful in appeal of Relistor label expansion CRL

      Headlines

      Mon, 14 Jul 2014

      advance illness receiving palliative care when the response to laxatives has been insufficient. Ad Comm briefing docs (NASDAQ: PGNX ) shares are up 12% premarket on robust volume. SLXP premarket activity is unavailable. Post your comment!

    5. What Does A Positive Adcom Mean For Progenics And Salix?

      Headlines

      Tue, 17 Jun 2014

      However, I rarely write about what happens after an Advisory Committee (Adcom) makes a decision. In the case of Progenics ( PGNX ), I believe that the Adcom has just handed down a significant decision that will help the company (should the FDA adopt it

    6. $5 Or Less: 3 Small, Speculative Biotechs On The Move

      Headlines

      Tue, 17 Jun 2014

      By Bret Jensen : I have found some of my biggest winners have come from small cap stocks selling for less than $5 a share. These companies receive scant analyst coverage, and one must do the research to uncover hidden gems. I personally look at myriad factors when analyzing the space. Insider ...

    7. Progenics schedules conference call to discuss Ad Comm recommendation

      Headlines

      Thu, 12 Jun 2014

      Progenics Pharmaceuticals ( PGNX +9.2% ) CEO Mark Baker will comment tomorrow in a conference call on the FDA's Anesthetic and Analgesic Drug Products Ad

    8. Ad Comm recommendation bodes well for opioid-induced constipation drugs

      Headlines

      Thu, 12 Jun 2014

      the FDA, would potentially mitigate a time-consuming and expensive hurdle for the drug makers in their NDA application efforts. Related tickers: ( CBST -0.6% ) ( NKTR ) ( SLXP +3.2% ) ( THRX -2.4% ) ( PGNX ) Post your comment!

    9. It’s Never Too Early: Roth 401(k)s and Other Fun Stuff

      Headlines

      Thu, 3 Apr 2014

      Progenics Pharmaceuticals PGNX announced on March 6 that it would backtrack and reformulate the oral version opioid bowel dysfunction drug MNTX to make it more

    « Prev12345Next »
    Content Partners